Mavyret is a prescription medication used to treat chronic hepatitis C virus (HCV) infection. It is a combination of two drugs: glecaprevir and pibrentasvir.
If you are pregnant or planning to become pregnant, it is important to talk to your healthcare provider about the potential risks and benefits of taking Mavyret. There is limited information available about the safety of Mavyret during pregnancy. In animal studies, glecaprevir and pibrentasvir have not been shown to cause harm to the fetus. However, animal studies do not always predict how a medication will affect humans.
HCV infection during pregnancy can cause serious health problems for the mother and the baby. If you are pregnant and have an HCV infection, it is important to discuss the risks and benefits of treatment with your healthcare provider. They can help you decide whether Mavyret is an appropriate treatment option for you.
It is also important to use effective contraception while taking Mavyret, as the medication can be harmful to a developing fetus. If you become pregnant while taking Mavyret, it is important to inform your healthcare provider immediately.
Overall, the decision to use Mavyret during pregnancy should be made after careful consideration of the potential risks and benefits, in consultation with your healthcare provider.
What is the hepatitis C virus (HCV)?
The hepatitis C virus (HCV) is a contagious virus that causes liver inflammation, often leading to serious liver damage. HCV is transmitted through contaminated blood.
HCV infection is a leading cause of liver disease and can be serious, even life-threatening. However, HCV infection can be cured with antiviral medications. Early diagnosis and treatment can prevent complications and long-term health problems associated with HCV infection.
Symptoms of HCV infection may
include fatigue, muscle, and joint aches, loss of appetite, nausea, abdominal pain, and jaundice (yellowing of the skin and whites of the eyes). However, many people with HCV infection do not have any symptoms and may not know they are infected.
If you think you may be at risk of HCV infection, it is important to talk to your healthcare provider. They can test you for HCV and recommend treatment if necessary.
Should You and your healthcare provider discuss the risks and benefits of Mavyret before treatment begins?
Yes, it is important to discuss the risks and benefits of Mavyret with your healthcare provider before starting treatment. Your healthcare provider will consider your specific situation, including your overall health, the severity of your HCV infection, and any other medications you are taking when determining whether Mavyret is an appropriate treatment option for you.
It is also important to inform your healthcare provider about any other medical conditions you have, as well as any medications you are taking, including over-the-counter drugs, supplements, and herbal remedies. This information can help your healthcare provider determine the best treatment plan for you.
If you have any questions or concerns about Mavyret or your treatment, be sure to discuss them with your healthcare provider. They can provide you with more information about the medication and its potential risks and benefits.
Should Mavyret is usually taken once daily with meals?
Yes, Mavyret is usually taken once daily with food. It is important to take Mavyret exactly as directed by your healthcare provider. Do not change your dose or stop taking Mavyret without first talking to your healthcare provider.
Mavyret is a combination of two medications, glecaprevir, and pibrentasvir, that are used to treat chronic hepatitis C virus (HCV) infection. It is available in the form of a tablet that is taken orally. It is usually taken once daily with food.
It is important to take Mavyret at the same time each day to help ensure that you do not miss a dose. If you forget to take a dose, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and take your next dose at the regular time. Do not take two doses of Mavyret at the same time to make up for a missed dose.
If you have any questions about how to take Mavyret, be sure to ask your healthcare provider or pharmacist. They can provide you with more information about the proper use of this medication.
Is Mavyret a brand of medicine?
Yes, that is correct. Mavyret is a brand of medicine that is used to treat chronic hepatitis C virus (HCV) infection. It is a combination of two medications, glecaprevir, and pibrentasvir, that work together to inhibit the replication of HCV and reduce the amount of virus in the body.
Mavyret is available in two step-down treatment options: an 8-week treatment option for patients without cirrhosis (a type of liver damage) or with compensated cirrhosis (a type of liver damage that is not causing severe symptoms) and a 12-week treatment option for patients with decompensated cirrhosis (a type of liver damage that is causing severe symptoms).
The decision about which treatment option is appropriate for you will depend on the severity of your HCV infection and your overall health. Your healthcare provider will consider your specific situation when determining the most appropriate treatment plan for you.
It is important to take Mavyret exactly as directed by your healthcare provider. Do not change your dose or stop taking Mavyret without first talking to your healthcare provider. If you have any questions about your treatment, be sure to ask your healthcare provider. They can provide you with more information about the use of Mavyret and its potential risks and benefits.
What recommended dose glecaprevir and pibrentasvir tablets?
The recommended dose of Mavyret is one 120mg glecaprevir and 28mg pibrentasvir tablet taken orally once daily with food for 12 weeks. This is the recommended treatment duration for patients with decompensated cirrhosis (a type of liver damage that is causing severe symptoms).
It is important to take Mavyret exactly as directed by your healthcare provider. Do not change your dose or stop taking Mavyret without first talking to your healthcare provider. If you have any questions about your treatment, be sure to ask your healthcare provider. They can provide you with more information about the use of Mavyret and its potential risks and benefits.
.png)
